NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Cybersecurity Stocks Plummet Amid "Mini-Flash-Crash"

The Indian cybersecurity sector has been severely impacted by the recent "mini-flash-crash" in the US, triggered by the rollout of Anthropic's new AI tool, Claude Code Security. This automated artificial intelligence tool scans codebases for vulnerabilities, leading to a significant decline in stocks.

Key Performers:

  • TAC Infosec Ltd: declined by 14.67%
  • TechD Cybersecurity: fell by 13.34%
  • Quick Heal Technologies: dropped by 5%
  • Sattrix Information Security: declined by 5%
  • Sasken Technologies: fell by 2%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-based Cybersecurity Companies Affected:

  • Palo Alto Networks: saw its stock slide by almost 9% since the launch, with a market capitalization of $116 billion
  • CrowdStrike: experienced a greater loss, with its share prices falling by 18% since February 20, erasing $20 billion in market cap
  • Cloudflare: down by 18.5%, wiping out $11.2 billion
  • Zscaler: down by 17.3%, erasing $4.6 billion
  • Okta: down by 16.7%, wiping out $2.6 billion

Anthropic's Claude Code Security uses advanced AI to scan codebases for vulnerabilities, validating each finding to minimize false positives and suggesting patches for review and approval. Its most advanced model, Claude Opus 4.6, has already identified over 500 high-severity vulnerabilities that have survived decades of expert review.

Investor Takeaway

Investors should be cautious of the decline in Indian cybersecurity stocks due to concerns over Claude Code Security vulnerabilities.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.